Association of manganese superoxide dismutase expression with progression of carcinogenesis in Barrett esophagus

Archives of Surgery

Volumn 140, Issue 12, 2005, Pages 1204-1209

  Hermann, Bruce ^a   Li, Yan ^a   Ray, Mukunda B ^a   Wo, John M ^a   Martin II, Robert C G ^a,b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MANGANESE SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; BARRETT ESOPHAGUS; CANCER GROWTH; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DYSPLASIA; ESOPHAGEAL ADENOCARCINOMA; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MUCOSA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; SUBMUCOSA;

ADENOCARCINOMA; AGED; ANALYSIS OF VARIANCE; BARRETT ESOPHAGUS; DISEASE PROGRESSION; DOWN-REGULATION; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; STATISTICS, NONPARAMETRIC; SUPEROXIDE DISMUTASE;

EID: 29144518721     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.140.12.1204     Document Type: Article

References (36)

1. Thompson WG, Heaton KW. Heartburn and globus in apparently healthy people. Can Med Assoc J. 1982;126:46-48.
2. Isolauri J, Luostarinen M, Isolauri E, Reinikainen P, Viljakka M, Keyrilainen O. Natural course of gastroesophageal reflux disease: 17-22 year follow-up of 60 patients. Am J Gastroenterol. 1997;92:37-41.
3. Cameron AJ. Barrett's esophagus: does the incidence of adenocarcinoma matter? Am J Gastroenterol. 1997;92:193-194.
4. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA. 1991;265:1287-1289.
5. Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology. 1993;104:510-513.
6. Katzka DA. Barrett's esophagus: surveillance and treatment. Gastroenterol Clin North Am. 2002;31:481-497.
7. Whittles CE, Biddlestone LR, Burton A, et al. Apoptotic and proliferative activity in the neoplastic progression of Barrett's oesophagus: a comparative study. J Pathol. 1999;187:535-540.
8. Fitzgerald RC, Triadafilopoulos G. Recent developments in the molecular characterization of Barrett's esophagus. Dig Dis. 1998;16:63-80.
9. Sahu SC, Washington MC. Effects of antioxidants on quercetin-induced nuclear DNA damage and lipid peroxidation. Cancer Lett. 1991;60:259-264.
10. Ohshima H, Bartsch H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat Res. 1994;305:253-264.
11. Fridovich I. Superoxide dismutases. Annu Rev Biochem. 1975;44:147-159.
12. Beyer W, Imlay J, Fridovich I. Superoxide dismutases. Prog Nucleic Acid Res Mol Biol. 1991;40:221-253.
13. McCord JM, Fridovich I. Superoxide dismutase: an enzymic function for erythrocuprein (hemocuprein). J Biol Chem. 1969;244:6049-6055.
14. Marklund SL. Human copper-containing superoxide dismutase of high molecular weight. Proc Natl Acad Sci U S A. 1982;79:7634-7638.
15. Weisiger RA, Fridovich I. Mitochondrial superoxide simutase: site of synthesis and intramitochondrial localization. J Biol Chem. 1973;248:4793-4796.
16. Church SL, Grant JW, Ridnour LA, et al. Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells. Proc Natl Acad Sci U S A. 1993;90:3113-3117.
17. Zhao Y, Xue Y, Oberley TD, et al. Overexpression of manganese superoxide dismutase suppresses tumor formation by modulation of activator protein-1 signaling in a multistage skin carcinogenesis model. Cancer Res. 2001;61:6082-6088.
18. Zhao Y, Oberley TD, Chaiswing L, et al. Manganese superoxide dismutase deficiency enhances cell turnover via tumor promoter-induced alterations in AP-1 and p53-mediated pathways in a skin cancer model. Oncogene. 2002;21:3836-3846.
19. Safford SE, Oberley TD, Urano M, St Clair DK. Suppression of fibrosarcoma metastasis by elevated expression of manganese superoxide dismutase. Cancer Res. 1994;54:4261-4265.
20. Li JJ, Oberley LW, St Clair DK, Ridnour LA, Oberley TD. Phenotypic changes induced in human breast cancer cells by overexpression of manganesecontaining superoxide dismutase. Oncogene. 1995;10:1989-2000.
21. Li N, Oberley TD, Oberley LW, Zhong W. Overexpression of manganese superoxide dismutase in DU145 human prostate carcinoma cells has multiple effects on cell phenotype. Prostate. 1998;35:221-233.
22. Li Y, Wo JM, Cai L, et al. Association of metallothionein expression and lack of apoptosis with progression of carcinogenesis in Barrett's esophagus. Exp Biol Med (Maywood). 2003;228:286-292.
23. St Clair DK, Wan XS, Kuroda M, Vichitbandha S, Tsuchida E, Urano M. Suppression of tumor metastasis by manganese superoxide dismutase is associated with reduced tumorigenicity and elevated fibronectin. Oncol Rep. 1997;4:753-757.
24. Hernandez-Saavedra D, McCord JM. Paradoxical effects of thiol reagents on Jurkat cells and a new thiol-sensitive mutant form of human mitochondrial superoxide dismutase. Cancer Res. 2003;63:159-163.
25. Li Y, Huang TT, Carlson EJ, et al. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet. 1995;11:376-381.
26. Wispe JR, Warner BB, Clark JC, et al. Human Mn-superoxide dismutase in pulmonary epithelial cells of transgenic mice confers protection from oxygen injury. J Biol Chem. 1992;267:23937-23941.
27. Yen HC, Oberley TD, Vichitbandha S, Ho YS, St Clair DK. The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice. J Clin Invest. 1996;98:1253-1260.
28. Yen HC, Oberley TD, Gairola CG, Szweda LI, St Clair DK. Manganese superoxide dismutase protects mitochondrial complex I against adriamycin-induced cardiomyopathy in transgenic mice. Arch Biochem Biophys. 1999;362:59-66.
29. Janssen AM, Bosman CB, van Duijn W, et al. Superoxide dismutases in gastric and esophageal cancer and the prognostic impact in gastric cancer. Clin Cancer Res. 2000;6:3183-3192.
30. Malafa M, Margenthaler J, Webb B, Neitzel L, Christophersen M. MnSOD expression is increased in metastatic gastric cancer. J Surg Res. 2000;88:130-134.
31. Hur GC, Cho SJ, Kim CH, et al. Manganese superoxide dismutase expression correlates with chemosensitivity in human gastric cancer cell lines. Clin Cancer Res. 2003;9:5768-5775.
32. Izutani R, Katoh M, Asano S, Ohyanagi H, Hirose K. Enhanced expression of manganese superoxide dismutase mRNA and increased TNFalpha mRNA expression by gastric mucosa in gastric cancer. World J Surg. 1996;20:228-233.
33. Izutani R, Asano S, Imano M, Kuroda D, Kato M, Ohyanagi H. Expression of manganese superoxide dismutase in esophageal and gastric cancers. J Gastroenterol. 1998;33:816-822.
34. Izutani R, Kato M, Asano S, Imano M, Ohyanagi H. Expression of manganese superoxide disumutase influences chemosensitivity in esophageal and gastric cancers. Cancer Detect Prev. 2002;26:213-221.
35. Kawaguchi T, Suzuki K, Matsuda Y, et al. Serum-manganese-superoxide dismutase: normal values and increased levels in patients with acute myocardial infarction and several malignant diseases determined by an enzyme-linked immunosorbent assay using a monoclonal antibody. J Immunol Methods. 1990;127:249-254.
36. Korenaga D, Yasuda M, Honda M, Nozoe T, Inutsuka S. MnSOD expression within tumor cells is closely related to mode of invasion in human gastric cancer. Oncol Rep. 2003;10:27-30.